应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MDGL Madrigal Pharmaceuticals, Inc.
休市中 04-26 16:00:00 EDT
193.33
-1.05
-0.54%
盘后
193.00
-0.33
-0.17%
19:39 EDT
最高
195.58
最低
189.00
成交量
45.33万
今开
192.49
昨收
194.38
日振幅
3.39%
总市值
40.59亿
流通市值
26.06亿
总股本
2,099万
成交额
8,751万
换手率
3.36%
流通股本
1,348万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Madrigal Pharmaceuticals, Inc.跌2.37% 股价跌破200美元大关
自选股智能写手 · 04-25 21:35
Madrigal Pharmaceuticals, Inc.跌2.37% 股价跌破200美元大关
Madrigal Pharmaceuticals, Inc.盘中异动 急速拉升5.05%报224.27美元
自选股智能写手 · 04-23
Madrigal Pharmaceuticals, Inc.盘中异动 急速拉升5.05%报224.27美元
BUZZ-美国银行将 Madrigal Pharma 评级定为 "跑输大市",该公司股价下跌
Reuters · 04-22
BUZZ-美国银行将 Madrigal Pharma 评级定为 "跑输大市",该公司股价下跌
Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报201.42美元
自选股智能写手 · 04-22
Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报201.42美元
Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.07%
自选股智能写手 · 04-20
Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.07%
BUZZ-Madrigal Pharma 获得 6 亿美元增资,股价下跌
Reuters · 03-19
BUZZ-Madrigal Pharma 获得 6 亿美元增资,股价下跌
隔夜美股全复盘(3.16)| 三大股指全线收跌,加密板块低开高走;Adobe大跌14%,FY24Q1净利不及预期,Q2营收指引低于分析师预期
格隆汇 · 03-16
隔夜美股全复盘(3.16)| 三大股指全线收跌,加密板块低开高走;Adobe大跌14%,FY24Q1净利不及预期,Q2营收指引低于分析师预期
嗡嗡声--美国股票走势-WW 国际公司、Madrigal 公司、美光技术公司
Reuters · 03-15
嗡嗡声--美国股票走势-WW 国际公司、Madrigal 公司、美光技术公司
BUZZ-Madrigal公司脂肪肝药物获美国食品及药物管理局批准,业绩大增
Reuters · 03-15
BUZZ-Madrigal公司脂肪肝药物获美国食品及药物管理局批准,业绩大增
加载更多
公司概况
公司名称:
Madrigal Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司,致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命,包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。
发行价格:
--
{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":193.33,"timestamp":1714161600000,"preClose":194.38,"halted":0,"volume":453346,"hourTrading":{"tag":"盘后","latestPrice":193,"preClose":193.33,"latestTime":"19:39 EDT","volume":6642,"amount":1284011.27,"timestamp":1714174757815},"delay":0,"floatShares":13479170,"shares":20993578,"eps":-19.993284,"marketStatus":"休市中","marketStatusCode":7,"change":-1.05,"latestTime":"04-26 16:00:00 EDT","open":192.49,"high":195.58,"low":189,"amount":87510711.21724,"amplitude":0.033851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-19.993284,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"adjPreClose":194.38,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":194,"preClose":194.38,"latestTime":"09:26 EDT","volume":636,"amount":122365.08348,"timestamp":1714138008030},"postHourTrading":{"tag":"盘后","latestPrice":193,"preClose":193.33,"latestTime":"19:39 EDT","volume":6642,"amount":1284011.27,"timestamp":1714174757815},"volumeRatio":0.744472328497752},"requestUrl":"/m/hq/s/MDGL","defaultTab":"news","newsList":[{"id":"2430286719","title":"Madrigal Pharmaceuticals, Inc.跌2.37% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286719","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286719?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:35","pubTimestamp":1714052150,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时35分,Madrigal Pharmaceuticals, Inc.股票出现异动,股价快速下跌2.37%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。Madrigal Pharmaceuticals, Inc.公司简介:Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下:Madrigal Pharmaceuticals获B of A Securities首次覆盖,给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213550861e9088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213550861e9088&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429191631","title":"Madrigal Pharmaceuticals, Inc.盘中异动 急速拉升5.05%报224.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429191631","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429191631?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:50","pubTimestamp":1713883848,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时50分,Madrigal Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.56%。Madrigal Pharmaceuticals, Inc.公司简介:Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下:Madrigal Pharmaceuticals获B of A Securities首次覆盖,给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250487922b450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250487922b450&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973103","title":"BUZZ-美国银行将 Madrigal Pharma 评级定为 \"跑输大市\",该公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973103","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429973103?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:35","pubTimestamp":1713800134,"startTime":"0","endTime":"0","summary":" 4月22日 - ** Madrigal Pharmaceuticals 股价下跌 6.3% 至 198.69 美元** BofA 券商给予该公司 \"跑输大市 \"评级,目标价为 150 美元。)** BofA 预测峰值销售额为 41 亿美元,低于 55 亿美元的一致预期。** MDGL 股价今年以来下跌约 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973508","title":"Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报201.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973508","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429973508?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:12","pubTimestamp":1713798744,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时12分,Madrigal Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.01%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。Madrigal Pharmaceuticals, Inc.公司简介:Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下:Madrigal Pharmaceuticals获B of A Securities首次覆盖,给予低于大市评级, 目标价150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042223122479225f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042223122479225f4e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428662791","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428662791","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428662791?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:33","pubTimestamp":1713547998,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时33分,Madrigal Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.07%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Nkgen Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation涨幅较大,Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为241.62%、15.55%、14.71%,振幅较大的相关个股有Nkgen Biotech, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为62.28%、46.41%、38.01%。Madrigal Pharmaceuticals, Inc.公司简介:Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420013318861e780c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420013318861e780c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420124461","title":"BUZZ-Madrigal Pharma 获得 6 亿美元增资,股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2420124461","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420124461?lang=zh_cn&edition=full","pubTime":"2024-03-19 19:03","pubTimestamp":1710846202,"startTime":"0","endTime":"0","summary":" 3月19日 - ** Madrigal Pharmaceuticals 的 股价在隔夜后续定价后盘前下跌 4.6%,报 270.15 美元。** 该公司于周一晚些时候出售了 ~2.3 百万股,包括 ~1.6 百万股预先融资的认股权证,总收益为 6 亿美元。** MDGL 周五收盘上涨 11%,报收于 270.37 美元,此前该公司治疗非酒精性脂肪性肝炎的药物首次获得 FDA 批准 ** 该公司有约 1990 万股已发行股票,市值 56 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419136837","title":"隔夜美股全复盘(3.16)| 三大股指全线收跌,加密板块低开高走;Adobe大跌14%,FY24Q1净利不及预期,Q2营收指引低于分析师预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2419136837","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2419136837?lang=zh_cn&edition=full","pubTime":"2024-03-16 05:27","pubTimestamp":1710538062,"startTime":"0","endTime":"0","summary":"三大股指全线收跌,加密板块低开高走;Adobe大跌14%,FY24Q1净利不及预期,Q2营收指引低于分析师预期","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/707911","is_publish_highlight":false,"gpt_icon":0},{"id":"2419274639","title":"嗡嗡声--美国股票走势-WW 国际公司、Madrigal 公司、美光技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2419274639","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419274639?lang=zh_cn&edition=full","pubTime":"2024-03-15 19:47","pubTimestamp":1710503278,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 3月15日 - 追踪华尔街主要股指的期货周五小幅走高,此前美国国债收益率在上一交易日大幅上涨后得到喘息,为股指的周线上涨奠定了基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419239099","title":"BUZZ-Madrigal公司脂肪肝药物获美国食品及药物管理局批准,业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2419239099","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419239099?lang=zh_cn&edition=full","pubTime":"2024-03-15 17:59","pubTimestamp":1710496767,"startTime":"0","endTime":"0","summary":" 3月15日 - ** 药物开发商Madrigal Pharmaceuticals 股价盘前上涨23.7%至301.20美元** 美国食品和药物管理局周四晚些时候批准了 co 公司治疗脂肪肝的药物,使其成为首个获得批准的脂肪肝治疗药物。** MDGL的口服药物将从4月起以Rezdiffra的品牌名称上市。** 该公司已将这种药物的年批发价定为47,400美元** 在Rezdiffra获批后,Viking Therapeutics 的股价盘前上涨约3.6%至67.38美元。** 截至上次收盘,MDGL 在过去 12 个月中上涨了 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":-0.0882},{"period":"1month","weight":-0.253},{"period":"3month","weight":-0.1444},{"period":"6month","weight":0.6057},{"period":"1year","weight":-0.3657},{"period":"ytd","weight":-0.1644}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司,致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命,包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.032263},{"month":2,"riseRate":0.75,"avgChangeRate":0.088162},{"month":3,"riseRate":0.25,"avgChangeRate":-0.038862},{"month":4,"riseRate":0.5,"avgChangeRate":0.003684},{"month":5,"riseRate":0.285714,"avgChangeRate":0.170435},{"month":6,"riseRate":0.571429,"avgChangeRate":0.00101},{"month":7,"riseRate":0,"avgChangeRate":-0.103727},{"month":8,"riseRate":0.625,"avgChangeRate":0.081916},{"month":9,"riseRate":0.375,"avgChangeRate":0.16708},{"month":10,"riseRate":0.625,"avgChangeRate":0.051439},{"month":11,"riseRate":0.5,"avgChangeRate":0.037474},{"month":12,"riseRate":0.5,"avgChangeRate":0.475789}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}